<p>Classification of NSCLC according to PD-L1 expression patterns in tumor-nest and TME compartments.</p
To better understand the expression pattern of programmed death-ligand 1 (PD-L1) expression in diffe...
Co-localized and diagnostically similar cancers: classification of model sites with their positions ...
Cyclin D1 immunostaining of non-neoplastic cells has been a source of diagnostic confusion especiall...
<p><b>A</b>: Pattern I—Constitutive mixed with induced. Diffuse expression of PD-L1 (IHC) on tumor c...
PD-L1 expression determination defines eligibility for treatment with pembrolizumab in patients with...
<p><b>A</b>: Percentage of positive cells for each biomarker in “All Cells” (tumor nest and TME comp...
We investigated the association of T1/T2 mapping values with programmed death-ligand 1 protein (PD-L...
(A) PD-L1 expression by IHC on both TC and IC for each subgroup. (B) PD-L1 IHC scoring criteria on T...
<p>Red arrows indicate PSMA-positive neovasculature endothelial cells (NEC) of tumor tissues. Black ...
<p>pDCs were identified in different tissues as BDCA-2<sup>+</sup> ILT3<sup>+</sup> positive cells (...
Programmed death 1 (PD-1) protein and its ligands, PD-L1 are two proteins that have been widely stud...
PD-L1 (programmed death-ligand 1) also called CD274 or B7-H1 is a membrane protein involved in the n...
<p><b>(A)</b> Representative images of H&E (upper left), tissue before (upper right) and after (lowe...
Metastatic non-small cell lung cancer (NSCLC) is a highly fatal and immunogenic malignancy. Although...
<p>Barplots depict the number of samples with high, low and negative expression of (A, B) PD-1 and (...
To better understand the expression pattern of programmed death-ligand 1 (PD-L1) expression in diffe...
Co-localized and diagnostically similar cancers: classification of model sites with their positions ...
Cyclin D1 immunostaining of non-neoplastic cells has been a source of diagnostic confusion especiall...
<p><b>A</b>: Pattern I—Constitutive mixed with induced. Diffuse expression of PD-L1 (IHC) on tumor c...
PD-L1 expression determination defines eligibility for treatment with pembrolizumab in patients with...
<p><b>A</b>: Percentage of positive cells for each biomarker in “All Cells” (tumor nest and TME comp...
We investigated the association of T1/T2 mapping values with programmed death-ligand 1 protein (PD-L...
(A) PD-L1 expression by IHC on both TC and IC for each subgroup. (B) PD-L1 IHC scoring criteria on T...
<p>Red arrows indicate PSMA-positive neovasculature endothelial cells (NEC) of tumor tissues. Black ...
<p>pDCs were identified in different tissues as BDCA-2<sup>+</sup> ILT3<sup>+</sup> positive cells (...
Programmed death 1 (PD-1) protein and its ligands, PD-L1 are two proteins that have been widely stud...
PD-L1 (programmed death-ligand 1) also called CD274 or B7-H1 is a membrane protein involved in the n...
<p><b>(A)</b> Representative images of H&E (upper left), tissue before (upper right) and after (lowe...
Metastatic non-small cell lung cancer (NSCLC) is a highly fatal and immunogenic malignancy. Although...
<p>Barplots depict the number of samples with high, low and negative expression of (A, B) PD-1 and (...
To better understand the expression pattern of programmed death-ligand 1 (PD-L1) expression in diffe...
Co-localized and diagnostically similar cancers: classification of model sites with their positions ...
Cyclin D1 immunostaining of non-neoplastic cells has been a source of diagnostic confusion especiall...
DOI
Add to ORKG